Member Info for Lostapound

As I posted in response

"It did mention risks, but I chose not to include those.

As you ask, the main two risks were finance considerations and price volitility."

One AI bot studying shares has predicted a potential drop down to £3.50, based on the fall from £17 and news flow etc, but generally staying in the £4.5-£6.50 region, until any news arrives.

@saint68

you seem to have spammed this thread with stuff about @Aldebaran. Was this a mistake?

It did mention risks, but I chose not to include those.

As you ask, the main two risks were finance considerations and price volitility.

One AI bot studying shares has predicted a potential drop down to £3.50, based on the fall from £17 and news flow etc, but generally staying in the £4.5-£6.50 region, until any news arrives.

Someone's playing around around with the 300 autotrades

And this is why the ongoing months long delay, waiting for outsourcing to complete, as mentioned by Vlad in his video interview, is a bit of a kick in the proverbials.

And this is why the ongoing months long delay waiting for outsourcing to complete is a bit of a kick in the proverbials.

And this is why the ongoing months long delay waiting for outsourcing to complete is a bit of a kick in the proverbials.

And this is why the ongoing months long delay waiting for outsourcing to complete is a bit of a kick in the proverbials.

Both 'sides' talking absolute tosh at the moment.

I guess i file this away in the folder titled 'bo11ocks'

i guess i file this away in the folder titled '******'

Google AI mentioned Hemo at ASH but referenced a year old video I which Vlad mentions the ASH Conference. It now says no official announcement about Hemogenyx and ASH.

I search the abstracts on the ASH website - nothing about Hemogenyx.

If I'm missing please post the link.

I get nothing.

11 months ago I think Vlad mentioned ASH Conference. But they are not on the current list on the official ASH website.

And this is confirmed where?

We know the basic results of the first 3 patients. Vlad has said he is in discussions with some pharmaceutical companies. The process of creating the CAR-T is being outsourced.

We currently do not know how far along this outsourcing is, and how long it will take, including test runs.

We are currently floating in a no-news period, with potential for news to drop. The price will fluctuate as traders trade.

And the minus 68k?

19k buy printed an hour late